REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
PLEX PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/27/2026
Trademark type
Combined
Nice classes
42
Filing date
05/02/2018
Registration date
07/27/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/05/2018
First use in commerce
11/14/2018
Drawing code
3
Owner type
03
Owner location
Petaluma, CA, US
Examiner
ONUOHA, UKACHUKWU FREDERICK
Law office
O20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "PLEX" in blue font above the stylized word "PHARMACEUTICALS" in blue font. To the left of the wording is an oval with a gradation of ribbon-like swirl patterns ranging from shades of white, blue, gray, and green.
Holders and representatives
Holders
Collidion, Inc.
Collidion, Inc.
Representatives
Dean G. Stathakis UltimatEdge IP Law Group, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/23/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/22/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/26/2021
IUAF
USE AMENDMENT FILED
05/20/2021
EISU
TEAS STATEMENT OF USE RECEIVED
05/20/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/20/2020
EX4G
SOU EXTENSION 4 GRANTED
11/18/2020
EXT4
SOU EXTENSION 4 FILED
11/18/2020
EEXT
SOU TEAS EXTENSION RECEIVED
11/18/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/30/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/30/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/30/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2020
EX3G
SOU EXTENSION 3 GRANTED
05/19/2020
EXT3
SOU EXTENSION 3 FILED
05/19/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/19/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/22/2019
EX2G
SOU EXTENSION 2 GRANTED
11/21/2019
EXT2
SOU EXTENSION 2 FILED
11/20/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/17/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/18/2019
EX1G
SOU EXTENSION 1 GRANTED
05/16/2019
EXT1
SOU EXTENSION 1 FILED
05/16/2019
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/28/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/22/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/22/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/20/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/25/2018
PUBO
PUBLISHED FOR OPPOSITION
09/25/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/05/2018
ALIE
ASSIGNED TO LIE
08/20/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/07/2018
DOCK
ASSIGNED TO EXAMINER
08/06/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2018
NWAP
NEW APPLICATION ENTERED
05/05/2018
Continuous trademark protection
Get notified about every new filing that threatens PLEX PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.